Peptide Therapy Market Insights, Global Outlook and Forecast 2022-2028
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
The latest research study released by Market IntelliX evaluates market size and forecasts of Peptide Therapy in global, including the following market information:
Global Peptide Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide Therapy Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Peptide Therapy companies in 2021 (%)
The global Peptide Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Route of Administration Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Peptide Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Type, 2021 (%)
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration
Global Peptide Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Application, 2021 (%)
Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
Global Peptide Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide Therapy revenues share in global market, 2021 (%)
Key companies Peptide Therapy sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Peptide Therapy sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Peptide Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptide Therapy Overall Market Size
2.1 Global Peptide Therapy Market Size: 2021 VS 2028
2.2 Global Peptide Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Peptide Therapy Sales: 2017-2028
3 Company Landscape
3.1 Top Peptide Therapy Players in Global Market
3.2 Top Global Peptide Therapy Companies Ranked by Revenue
3.3 Global Peptide Therapy Revenue by Companies
3.4 Global Peptide Therapy Sales by Companies
3.5 Global Peptide Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Peptide Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Peptide Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peptide Therapy Players in Global Market
3.8.1 List of Global Tier 1 Peptide Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Peptide Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peptide Therapy Market Size Markets, 2021 & 2028
4.1.2 Parenteral Route of Administration
4.1.3 Mucosal Route of Administration
4.1.4 Oral Route of Administration
4.1.5 Transdermal Route of Administration
4.2 By Type - Global Peptide Therapy Revenue & Forecasts
4.2.1 By Type - Global Peptide Therapy Revenue, 2017-2022
4.2.2 By Type - Global Peptide Therapy Revenue, 2023-2028
4.2.3 By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Peptide Therapy Sales & Forecasts
4.3.1 By Type - Global Peptide Therapy Sales, 2017-2022
4.3.2 By Type - Global Peptide Therapy Sales, 2023-2028
4.3.3 By Type - Global Peptide Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Peptide Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular Diseases
5.1.4 Gastrointestinal Disorders
5.1.5 Metabolic Disorders
5.1.6 Others
5.2 By Application - Global Peptide Therapy Revenue & Forecasts
5.2.1 By Application - Global Peptide Therapy Revenue, 2017-2022
5.2.2 By Application - Global Peptide Therapy Revenue, 2023-2028
5.2.3 By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Peptide Therapy Sales & Forecasts
5.3.1 By Application - Global Peptide Therapy Sales, 2017-2022
5.3.2 By Application - Global Peptide Therapy Sales, 2023-2028
5.3.3 By Application - Global Peptide Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Peptide Therapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Peptide Therapy Market Size, 2021 & 2028
6.2 By Region - Global Peptide Therapy Revenue & Forecasts
6.2.1 By Region - Global Peptide Therapy Revenue, 2017-2022
6.2.2 By Region - Global Peptide Therapy Revenue, 2023-2028
6.2.3 By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Peptide Therapy Sales & Forecasts
6.3.1 By Region - Global Peptide Therapy Sales, 2017-2022
6.3.2 By Region - Global Peptide Therapy Sales, 2023-2028
6.3.3 By Region - Global Peptide Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Peptide Therapy Revenue, 2017-2028
6.4.2 By Country - North America Peptide Therapy Sales, 2017-2028
6.4.3 US Peptide Therapy Market Size, 2017-2028
6.4.4 Canada Peptide Therapy Market Size, 2017-2028
6.4.5 Mexico Peptide Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Peptide Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Peptide Therapy Sales, 2017-2028
6.5.3 Germany Peptide Therapy Market Size, 2017-2028
6.5.4 France Peptide Therapy Market Size, 2017-2028
6.5.5 U.K. Peptide Therapy Market Size, 2017-2028
6.5.6 Italy Peptide Therapy Market Size, 2017-2028
6.5.7 Russia Peptide Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Peptide Therapy Market Size, 2017-2028
6.5.9 Benelux Peptide Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Peptide Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Peptide Therapy Sales, 2017-2028
6.6.3 China Peptide Therapy Market Size, 2017-2028
6.6.4 Japan Peptide Therapy Market Size, 2017-2028
6.6.5 South Korea Peptide Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Peptide Therapy Market Size, 2017-2028
6.6.7 India Peptide Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Peptide Therapy Revenue, 2017-2028
6.7.2 By Country - South America Peptide Therapy Sales, 2017-2028
6.7.3 Brazil Peptide Therapy Market Size, 2017-2028
6.7.4 Argentina Peptide Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peptide Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Peptide Therapy Sales, 2017-2028
6.8.3 Turkey Peptide Therapy Market Size, 2017-2028
6.8.4 Israel Peptide Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Peptide Therapy Market Size, 2017-2028
6.8.6 UAE Peptide Therapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Peptide Therapy Major Product Offerings
7.1.4 Eli Lilly Peptide Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Peptide Therapy Major Product Offerings
7.2.4 AstraZeneca Peptide Therapy Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Peptide Therapy Major Product Offerings
7.3.4 Merck Peptide Therapy Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Ipsen
7.4.1 Ipsen Corporate Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Peptide Therapy Major Product Offerings
7.4.4 Ipsen Peptide Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Ipsen Key News
7.5 Novo Nordisk
7.5.1 Novo Nordisk Corporate Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Peptide Therapy Major Product Offerings
7.5.4 Novo Nordisk Peptide Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Novo Nordisk Key News
7.6 Teva Pharmaceutical Industries
7.6.1 Teva Pharmaceutical Industries Corporate Summary
7.6.2 Teva Pharmaceutical Industries Business Overview
7.6.3 Teva Pharmaceutical Industries Peptide Therapy Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Peptide Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Teva Pharmaceutical Industries Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Peptide Therapy Major Product Offerings
7.7.4 Abbott Laboratories Peptide Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Abbott Laboratories Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Peptide Therapy Major Product Offerings
7.8.4 Sanofi Peptide Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 J & J
7.9.1 J & J Corporate Summary
7.9.2 J & J Business Overview
7.9.3 J & J Peptide Therapy Major Product Offerings
7.9.4 J & J Peptide Therapy Sales and Revenue in Global (2017-2022)
7.9.5 J & J Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Peptide Therapy Major Product Offerings
7.10.4 Novartis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Novartis Key News
7.11 Takeda
7.11.1 Takeda Corporate Summary
7.11.2 Takeda Peptide Therapy Business Overview
7.11.3 Takeda Peptide Therapy Major Product Offerings
7.11.4 Takeda Peptide Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Takeda Key News
7.12 Ferring
7.12.1 Ferring Corporate Summary
7.12.2 Ferring Peptide Therapy Business Overview
7.12.3 Ferring Peptide Therapy Major Product Offerings
7.12.4 Ferring Peptide Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Ferring Key News
7.13 AbbVie
7.13.1 AbbVie Corporate Summary
7.13.2 AbbVie Peptide Therapy Business Overview
7.13.3 AbbVie Peptide Therapy Major Product Offerings
7.13.4 AbbVie Peptide Therapy Sales and Revenue in Global (2017-2022)
7.13.5 AbbVie Key News
7.14 Heinis
7.14.1 Heinis Corporate Summary
7.14.2 Heinis Business Overview
7.14.3 Heinis Peptide Therapy Major Product Offerings
7.14.4 Heinis Peptide Therapy Sales and Revenue in Global (2017-2022)
7.14.5 Heinis Key News
7.15 Hemmo
7.15.1 Hemmo Corporate Summary
7.15.2 Hemmo Business Overview
7.15.3 Hemmo Peptide Therapy Major Product Offerings
7.15.4 Hemmo Peptide Therapy Sales and Revenue in Global (2017-2022)
7.15.5 Hemmo Key News
7.16 Emcure Pharmaceutical
7.16.1 Emcure Pharmaceutical Corporate Summary
7.16.2 Emcure Pharmaceutical Business Overview
7.16.3 Emcure Pharmaceutical Peptide Therapy Major Product Offerings
7.16.4 Emcure Pharmaceutical Peptide Therapy Sales and Revenue in Global (2017-2022)
7.16.5 Emcure Pharmaceutical Key News
7.17 Cipla
7.17.1 Cipla Corporate Summary
7.17.2 Cipla Business Overview
7.17.3 Cipla Peptide Therapy Major Product Offerings
7.17.4 Cipla Peptide Therapy Sales and Revenue in Global (2017-2022)
7.17.5 Cipla Key News
7.18 Gland Pharma
7.18.1 Gland Pharma Corporate Summary
7.18.2 Gland Pharma Business Overview
7.18.3 Gland Pharma Peptide Therapy Major Product Offerings
7.18.4 Gland Pharma Peptide Therapy Sales and Revenue in Global (2017-2022)
7.18.5 Gland Pharma Key News
7.19 Troikaa Pharmaceuticals
7.19.1 Troikaa Pharmaceuticals Corporate Summary
7.19.2 Troikaa Pharmaceuticals Business Overview
7.19.3 Troikaa Pharmaceuticals Peptide Therapy Major Product Offerings
7.19.4 Troikaa Pharmaceuticals Peptide Therapy Sales and Revenue in Global (2017-2022)
7.19.5 Troikaa Pharmaceuticals Key News
7.20 Biological E
7.20.1 Biological E Corporate Summary
7.20.2 Biological E Business Overview
7.20.3 Biological E Peptide Therapy Major Product Offerings
7.20.4 Biological E Peptide Therapy Sales and Revenue in Global (2017-2022)
7.20.5 Biological E Key News
8 Global Peptide Therapy Production Capacity, Analysis
8.1 Global Peptide Therapy Production Capacity, 2017-2028
8.2 Peptide Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Peptide Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peptide Therapy Supply Chain Analysis
10.1 Peptide Therapy Industry Value Chain
10.2 Peptide Therapy Upstream Market
10.3 Peptide Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peptide Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Peptide Therapy in Global Market
Table 2. Top Peptide Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Peptide Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Peptide Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Peptide Therapy Sales by Companies, (K Units), 2017-2022
Table 6. Global Peptide Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Peptide Therapy Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Peptide Therapy Product Type
Table 9. List of Global Tier 1 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Peptide Therapy Sales (K Units), 2017-2022
Table 15. By Type - Global Peptide Therapy Sales (K Units), 2023-2028
Table 16. By Application – Global Peptide Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Peptide Therapy Sales (K Units), 2017-2022
Table 20. By Application - Global Peptide Therapy Sales (K Units), 2023-2028
Table 21. By Region – Global Peptide Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Peptide Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Peptide Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Peptide Therapy Sales (K Units), 2017-2022
Table 25. By Region - Global Peptide Therapy Sales (K Units), 2023-2028
Table 26. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Peptide Therapy Sales, (K Units), 2017-2022
Table 29. By Country - North America Peptide Therapy Sales, (K Units), 2023-2028
Table 30. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Peptide Therapy Sales, (K Units), 2017-2022
Table 33. By Country - Europe Peptide Therapy Sales, (K Units), 2023-2028
Table 34. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Peptide Therapy Sales, (K Units), 2017-2022
Table 37. By Region - Asia Peptide Therapy Sales, (K Units), 2023-2028
Table 38. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Peptide Therapy Sales, (K Units), 2017-2022
Table 41. By Country - South America Peptide Therapy Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Peptide Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Peptide Therapy Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Peptide Therapy Product Offerings
Table 48. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Peptide Therapy Product Offerings
Table 51. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Peptide Therapy Product Offerings
Table 54. Merck Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ipsen Corporate Summary
Table 56. Ipsen Peptide Therapy Product Offerings
Table 57. Ipsen Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Novo Nordisk Corporate Summary
Table 59. Novo Nordisk Peptide Therapy Product Offerings
Table 60. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Teva Pharmaceutical Industries Corporate Summary
Table 62. Teva Pharmaceutical Industries Peptide Therapy Product Offerings
Table 63. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Abbott Laboratories Corporate Summary
Table 65. Abbott Laboratories Peptide Therapy Product Offerings
Table 66. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Peptide Therapy Product Offerings
Table 69. Sanofi Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. J & J Corporate Summary
Table 71. J & J Peptide Therapy Product Offerings
Table 72. J & J Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Novartis Corporate Summary
Table 74. Novartis Peptide Therapy Product Offerings
Table 75. Novartis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Takeda Corporate Summary
Table 77. Takeda Peptide Therapy Product Offerings
Table 78. Takeda Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Ferring Corporate Summary
Table 80. Ferring Peptide Therapy Product Offerings
Table 81. Ferring Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. AbbVie Corporate Summary
Table 83. AbbVie Peptide Therapy Product Offerings
Table 84. AbbVie Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Heinis Corporate Summary
Table 86. Heinis Peptide Therapy Product Offerings
Table 87. Heinis Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Hemmo Corporate Summary
Table 89. Hemmo Peptide Therapy Product Offerings
Table 90. Hemmo Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Emcure Pharmaceutical Corporate Summary
Table 92. Emcure Pharmaceutical Peptide Therapy Product Offerings
Table 93. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Cipla Corporate Summary
Table 95. Cipla Peptide Therapy Product Offerings
Table 96. Cipla Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Gland Pharma Corporate Summary
Table 98. Gland Pharma Peptide Therapy Product Offerings
Table 99. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Troikaa Pharmaceuticals Corporate Summary
Table 101. Troikaa Pharmaceuticals Peptide Therapy Product Offerings
Table 102. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. Biological E Corporate Summary
Table 104. Biological E Peptide Therapy Product Offerings
Table 105. Biological E Peptide Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Peptide Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Peptide Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Peptide Therapy Production by Region, 2017-2022 (K Units)
Table 109. Global Peptide Therapy Production by Region, 2023-2028 (K Units)
Table 110. Peptide Therapy Market Opportunities & Trends in Global Market
Table 111. Peptide Therapy Market Drivers in Global Market
Table 112. Peptide Therapy Market Restraints in Global Market
Table 113. Peptide Therapy Raw Materials
Table 114. Peptide Therapy Raw Materials Suppliers in Global Market
Table 115. Typical Peptide Therapy Downstream
Table 116. Peptide Therapy Downstream Clients in Global Market
Table 117. Peptide Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Peptide Therapy Segment by Type
Figure 2. Peptide Therapy Segment by Application
Figure 3. Global Peptide Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peptide Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peptide Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Peptide Therapy Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Peptide Therapy Revenue in 2021
Figure 9. By Type - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Peptide Therapy Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Peptide Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Peptide Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Peptide Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Peptide Therapy Sales Market Share, 2017-2028
Figure 19. US Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Peptide Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Peptide Therapy Sales Market Share, 2017-2028
Figure 24. Germany Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Peptide Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Peptide Therapy Sales Market Share, 2017-2028
Figure 33. China Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Peptide Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Peptide Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Peptide Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Peptide Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Peptide Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Peptide Therapy Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Peptide Therapy by Region, 2021 VS 2028
Figure 50. Peptide Therapy Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|